These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22064605)

  • 1. Comorbidities in gouty arthritis.
    Marwah RK
    J Investig Med; 2011 Dec; 59(8):1211-20. PubMed ID: 22064605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges associated with the management of gouty arthritis in patients with chronic kidney disease: a systematic review.
    Curiel RV; Guzman NJ
    Semin Arthritis Rheum; 2012 Oct; 42(2):166-78. PubMed ID: 22560299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of gouty arthritis in patients with chronic kidney disease.
    Abdellatif AA; Elkhalili N
    Am J Ther; 2014; 21(6):523-34. PubMed ID: 22960848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Difficult-to-treat gouty arthritis: a disease warranting better management.
    Schlesinger N
    Drugs; 2011 Jul; 71(11):1413-39. PubMed ID: 21812506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Human and Economic Burden of Difficult-to-Treat Gouty Arthritis.
    Bardin T; Voshaar MA; van de Laar MA
    Joint Bone Spine; 2015 Oct; 82 Suppl 1():eS2-8. PubMed ID: 26717799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics considerations for gout treatments.
    Richette P; Frazier A; Bardin T
    Expert Opin Drug Metab Toxicol; 2014 Jul; 10(7):949-57. PubMed ID: 24809930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal transition trajectory of gouty arthritis and its comorbidities: a population-based study.
    Huang CF; Liu JC; Huang HC; Chuang SY; Chen CI; Lin KC
    Rheumatol Int; 2017 Feb; 37(2):313-322. PubMed ID: 28004164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gouty arthritis: understanding the disease state and management options in primary care.
    Sunkureddi P
    Adv Ther; 2011 Sep; 28(9):748-60. PubMed ID: 21894471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current opinions on gout, its diagnosis and treatment].
    Němec P
    Vnitr Lek; 2012 Dec; 58(12):928-37. PubMed ID: 23427951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathogenesis, diagnostics and therapy of gout].
    Zurek M
    Vnitr Lek; 2006; 52(7-8):736-41. PubMed ID: 16967617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does prolonged systemic glucocorticoid use increase risk of tophus formation among gouty arthritis patients?
    Raso AA; Sto Niño OV; Li-Yu J
    Int J Rheum Dis; 2009 Sep; 12(3):243-9. PubMed ID: 20374354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in the management of gout and hyperuricaemia.
    Hoskison TK; Wortmann RL
    Scand J Rheumatol; 2006; 35(4):251-60. PubMed ID: 16882587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of asymptomatic hyperuricemia for the prevention of gouty arthritis, renal disease, and cardiovascular events: a systematic literature review.
    Vinik O; Wechalekar MD; Falzon L; Buchbinder R; van der Heijde DM; Bombardier C
    J Rheumatol Suppl; 2014 Sep; 92():70-4. PubMed ID: 25180131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of patient characteristics and gout-related health-care resource utilization and costs in patients with frequent versus infrequent gouty arthritis attacks.
    Saseen JJ; Agashivala N; Allen RR; Ghushchyan V; Yadao AM; Nair KV
    Rheumatology (Oxford); 2012 Nov; 51(11):2004-12. PubMed ID: 22829689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using serum urate levels to determine the period free of gouty symptoms after withdrawal of long-term urate-lowering therapy: a prospective study.
    Perez-Ruiz F; Atxotegi J; Hernando I; Calabozo M; Nolla JM
    Arthritis Rheum; 2006 Oct; 55(5):786-90. PubMed ID: 17013833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What makes gouty inflammation so variable?
    Terkeltaub R
    BMC Med; 2017 Aug; 15(1):158. PubMed ID: 28818081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P2X7R: a potential key regulator of acute gouty arthritis.
    Tao JH; Zhang Y; Li XP
    Semin Arthritis Rheum; 2013 Dec; 43(3):376-80. PubMed ID: 23786870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of hyperuricemia, gout and other crystalline arthritidies.
    Lioté F
    Reumatismo; 2012 Jan; 63(4):276-83. PubMed ID: 22303534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of anakinra for various types of crystal-induced arthritis in complex hospitalized patients: a case series and review of the literature.
    Aouba A; Deshayes S; Frenzel L; Decottignies A; Pressiat C; Bienvenu B; Boue F; Damaj G; Hermine O; Georgin-Lavialle S
    Mediators Inflamm; 2015; 2015():792173. PubMed ID: 25922564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gouty arthritis in acute cerebrovascular disease.
    Lin YH; Hsu HL; Huang YC; Lee M; Huang WY; Huang YC; Lee TH; Lee JD
    Cerebrovasc Dis; 2009; 28(4):391-6. PubMed ID: 19696479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.